Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-05-043193
Filing Date
2005-09-08
Accepted
2005-09-07 20:28:16
Documents
1
Group Members
CITADEL DERIVATIVES GROUP LLCCITADEL EQUITY FUND LTD.CITADEL INVESTMENT GROUP, L.L.C.CITADEL KENSINGTON GLOBAL STRATEGIES FUND LTD.CITADEL WELLINGTON LLCKENNETH GRIFFIN

Document Format Files

Seq Description Document Type Size
1 SC 13G a05-15855_1sc13g.htm SC 13G 240681
  Complete submission text file 0001104659-05-043193.txt   242811
Mailing Address 131 S. DEARBORN STREET, 32ND FLOOR CHICAGO IL 60603
Business Address 131 S. DEARBORN STREET, 32ND FLOOR CHICAGO IL 60606 3123952100
CITADEL L P (Filed by) CIK: 0001027745 (see all company filings)

EIN.: 364111741 | State of Incorp.: IL | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 7575 WEST 103RD AVENUE STE 102 WESTMINSTER CO 80021
Business Address 7575 WEST 103RD AVENUE STE 102 WESTMINSTER CO 80021 3034106666
MYOGEN INC (Subject) CIK: 0001101052 (see all company filings)

EIN.: 841348020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-79524 | Film No.: 051073918
SIC: 2834 Pharmaceutical Preparations